Reporting QCs [Bioanalytics]

posted by Charl – 2007-09-03 12:13 (6864 d 13:46 ago) – Posting: # 1053
Views: 8,637

dear ohlbe

I value your feed back notes :-)

❝ The FDA wants you to demonstrate the precision of your method using real-life samples, not only spiked samples. Meaning that if you want to comply with this requirement you will have to re-assay some of the samples from your study. The idea is to use the results of the first determination for your PK analysis, and have a table somewhere listing the results of whatever you will have done to demonstrate precision on incurred samples.

❝ You do not need to treat these results as per your procedure on repeat analysis to select which result should be reported.


what is the minimum re-analysis points is accepted to demonstrate reproducibility from the whole incurred samples?
re-analysis done in duplicate are enough?
what if my plasma sample volumes does not allow me to do re-analysis for more than twice? :-|


Regards
Charl

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
155 visitors (0 registered, 155 guests [including 17 identified bots]).
Forum time: 01:59 CEST (Europe/Vienna)

Actually, science starts to become interesting
only where it ends.    Justus von Liebig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5